Amgen

Welcome to the 'Amgen' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'Amgen'.

Latest blogosphere posts tagged “Amgen”

• NEL 2010 FARMACO CHE STIMOLA PRODUZIONE DI PIASTRINE

  
  SALUTE DOMANI ? IL PORTALE DEL BENESSERE — Authority: 151
  Progressi nella tutela della salute della donna: è in arrivo in Italia all’inizio del 2010 il primo farmaco che stimola la produzione piastrine: verrà utilizzato per trattare i pazienti che soffrono di una grave malattia del sangue e che sono risultati refrattari a tutte le terapie. Romiplostim, nome commerciale ...
  1 day ago

• Ironwood Pharma Eyes $172.5M IPO, Biogen CEO Pay Under Fire, & More Boston Life Sciences News

  
  Xconomy — Authority: 703
  Life Sciences , deals , Multiple Sclerosis Ryan McBride wrote: Xconomy’s life sciences coverage this past week featured a mix of exclusive feature stories—such as Luke’s analysis of the PML side effect from Biogen Idec’s natalizumab (Tysabri)—and breaking news stories like Ironwood ...
  1 day ago

• ImmunoGen Signs 2nd Licensing Deal with Amgen

  
  OneMedPlace — Authority: 420
  ImmunoGen has licensed its anti-cancer technology to Amgen for an upfront payment of $1 million. The deal gives biotechnology company Amgen the right to use ImmunoGen’s maytansinoid targeted antibody payload (TAP) technology to create cancer-fighting therapies to an undisclosed target. In addition to the ...
  3 days ago

• Enbrel web banner

  
  AdPharm Blog — Authority: 150
  Read the rest on AdPharms blog!
  4 days ago

• Metcalfe Reflects on $2.7B 3Com Buyout, $30M More for Fate Therapeutics, & More Boston Deals News

  
  Xconomy — Authority: 703
  deals , VC , mergers and acquisitions Ryan McBride wrote: Dealmakers appear to be getting their business done before the week of Thanksgiving—because we’ve seen a decent stream of deal closings involving Boston-area life sciences and tech companies over the past week or so. —Framingham, MA-based ...
  6 days ago

• ImmunoGen Nabs $1M From Amgen

  
  Xconomy — Authority: 703
  Biotech , deals , cancer Luke Timmerman wrote: Waltham, MA-based ImmunoGen (NASDAQ: IMGN ) said today that Amgen has purchased a second license to develop a treatment that uses ImmunoGen’s technology for linking targeted antibodies to cell-killing agents that make them more potent. ImmunoGen will get ...
  6 days ago

• Additional Wild Cards awarded to the BMC Racing Team

  
  Bike World News — Authority: 439
  After the Organizers of the Tour Down Under in Australia extended a Wild Card invitation to the BMC Racing Team for the 2010 edition, two additional invitations have arrived. For the full story, go to http://www.bikeworldnews.com
  1 week ago

• Floyd Landis and OUCH p/b Maxxis part ways

  
  Bike World News — Authority: 439
  Momentum Sports Group (MSG), the owners of the OUCH presented by Maxxis team, and Floyd Landis have mutually agreed to terminate Landis Rider Agreement and thereby release both Landis and MSG from... For the full story, go to http://www.bikeworldnews.com
  1 week ago

• Cash Just Kept On Piling Up, But It Looks Like The Spending Has Started

  
  Ohaiyo Business Magazine — Authority: 136
  Cash and equivalent, an item that is always near and dear to my heart, for the S&P old Industrials, which is the S&P 500 less Financials, Utilities, and Transportation issues, is running 9.8% ahead of the record setting second quarter value of $773 billion. Information Technology, lead by Oracle which ...
  1 week ago

• Enbrel web banner

  
  AdPharm Blog — Authority: 150
  Click here to see it on AdPharm AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here .
  1 week ago

• Enbrel web banner

  
  AdPharm Blog — Authority: 150
  Click here to see it on AdPharm AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here .
  2 weeks ago

• Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News

  
  Xconomy — Authority: 703
  Roundup , Biotech , deals Luke Timmerman wrote: This was the week that a little biotech company in Bothell that few of the locals have ever heard of, burst onto the national stage. —Bothell, WA-based Alder Biopharmaceuticals had its breakout moment this week when it pulled in $85 million in upfront ...
  2 weeks ago

• Amgens troubles keep compounding; Aranesp studies reveal greater risks

  
  DailyFinance — Authority: 805
  Filed under: Company News , Healthcare It seems that when it comes to Aranesp, its blockbuster anemia drug, Amgen ( AMGN ) just cant catch a break, nor for that matter, create one. Recently, Amgen was hit with a double whammy -- a lawsuit and an unfavorable study of the drug. On Tuesday, yet another study ...
  2 weeks ago

• Alder Rides Momentum of $1B Deal, Aims to Give Amgen and Abbott a Run for Their Money

  
  Xconomy — Authority: 703
  Biotech , deals , people Luke Timmerman wrote: Alder Biopharmaceuticals keeps such a low profile that even after five years in business, few people in Seattle biotech know who they are. That changed yesterday as the private Bothell, WA-based company burst onto the local, and national, biotech scene by ...
  2 weeks ago

• Alder Scores Deal With Bristol-Myers Potentially Worth $1 Billion

  
  Xconomy — Authority: 703
  Biotech , deals , Rheumatoid Arthritis Luke Timmerman wrote: Alder Biopharmaceuticals has just struck one of the biggest biotech partnerships of the year, both in the Seattle area and nationally. The Bothell, WA-based developer of faster and cheaper technology for making antibody drugs has formed a ...
  2 weeks ago

• Looking Back: 2009 Tour of California a Perfect Barometer for Later Season Success

  
  Euro Peloton - Pro Cycling News — Authority: 123
  The 2009 Amgen Tour of California proved to be a good barometer for who would shine in 2009. Held in February at the beginning of the season, the nine day race was long enough and tough enough to show who would have the chops later in the season. Now scheduled for May, next years race will be a great indicator for who ...
  2 weeks ago

• Aranesp Associated With Increased Risk For Stroke In Patients With Diabetes And Chronic Kidney Disease

  
  Drug Injury Watch — Authority: 114
  TREAT Study Revealed, Also, That This Amgen Anemia Drug Was No Better Than Placebo In Reducing Deaths Or Cardiovascular Problems (Posted by Tom Lamb at DrugInjuryWatch.com ) The anemia drug Aranesp (darbepoetin alfa) might cause an increased risk for stroke in patients with diabetes and ...
  2 weeks ago

• Impactiviti Daily 110209

  
  Impactiviti blog — Authority: 531
  TODAY’S NEWS Takeda buys into Amylin ’s weight-loss drug portfolio – Takeda will pay $75 million upfront for medicines including Amylin’s pramlintide/metreleptin and davalintide, in the second phase of testing needed for U.S. regulatory approval, Osaka- based Takeda and San Diego-based Amylin said in ...
  3 weeks ago

• Amylin Strikes $1 Billion Deal with Takeda to Co-Develop Weight Loss Drugs

  
  Xconomy — Authority: 703
  Biotech , deals , obesity Luke Timmerman wrote: San Diego-based Amylin Pharmaceuticals, the dark horse in the race to develop a new breed of weight-loss drugs, has struck a partnership with Japan-based Takeda Pharmaceuticals that could be worth more than $1 billion over time if the drug reaches ...
  3 weeks ago

• 15 States Including California Are Suing Amgen – Alleging Kickbacks and Overfill Billings to Boost Sales of Aranesp

  
  The Medical Quack — Authority: 534
  The drug, Aranesp is used with chemotherapy and chronic renal failure to increase red blood cells and was approved by the FDA in 2001. We are hearing more about drug marketing today and now it’s spilling over to the “biotech” drug companies for investigation. The suit states that providers were bribed and ...
  3 weeks ago

Comments about Amgen